These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 10640219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
    Dunlap J, Kelemen K, Leeborg N, Braziel R, Olson S, Press R, Huang J, Gatter K, Loriaux M, Fan G.
    Am J Clin Pathol; 2011 May; 135(5):709-19. PubMed ID: 21502425
    [Abstract] [Full Text] [Related]

  • 4. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD.
    Cancer Lett; 2007 Sep 18; 255(1):12-25. PubMed ID: 17383090
    [Abstract] [Full Text] [Related]

  • 5. Karyotype and molecular cytogenetic studies in polycythemia vera.
    Andrieux JL, Demory JL.
    Curr Hematol Rep; 2005 May 18; 4(3):224-9. PubMed ID: 15865876
    [Abstract] [Full Text] [Related]

  • 6. Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.
    O'Reilly J, Crawford J, Uzaraga J, Cannell P.
    Cancer Genet Cytogenet; 2005 Apr 01; 158(1):81-3. PubMed ID: 15771910
    [Abstract] [Full Text] [Related]

  • 7. [Karyotyping in chronic myeloproliferative syndrome (except chronic myeloid leukemia)].
    Lessard M.
    Pathol Biol (Paris); 1982 Nov 01; 30(9):759-65. PubMed ID: 6760079
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder.
    Smedley D, Somers G, Venter D, Chow CW, Cooper C, Shipley J.
    Genes Chromosomes Cancer; 1998 Jan 01; 21(1):70-3. PubMed ID: 9443043
    [Abstract] [Full Text] [Related]

  • 9. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Li F, Zhai YP, Tang YM, Wang LP, Wan PJ.
    Genes Chromosomes Cancer; 2012 Sep 01; 51(9):890-7. PubMed ID: 22619110
    [Abstract] [Full Text] [Related]

  • 10. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.
    Still IH, Cowell JK.
    Blood; 1998 Aug 15; 92(4):1456-8. PubMed ID: 9694738
    [No Abstract] [Full Text] [Related]

  • 11. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
    Bacher U, Haferlach T, Schoch C.
    Cancer Genet Cytogenet; 2005 Jul 15; 160(2):179-83. PubMed ID: 15993276
    [Abstract] [Full Text] [Related]

  • 12. Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders.
    Wan TS, Ma SK, Au WY, Chan LC.
    Cancer Genet Cytogenet; 2001 Jul 01; 128(1):35-8. PubMed ID: 11454427
    [Abstract] [Full Text] [Related]

  • 13. [The 8p11 myeloproliferative syndrome].
    Reither A, Hehlmann R, Goldman JM, Cross NC.
    Med Klin (Munich); 1999 Apr 15; 94(4):207-10. PubMed ID: 10373756
    [Abstract] [Full Text] [Related]

  • 14. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW, Habeebu S, Sheehan AM, Naeem R, Hernandez VS, Dreyer ZE, López-Terrada D.
    J Pediatr Hematol Oncol; 2009 Nov 15; 31(11):879-83. PubMed ID: 19829149
    [Abstract] [Full Text] [Related]

  • 15. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.
    Shaaban H, Dabu J, Al-Rabi K, Gauchan D, Guron G.
    Ann Hematol; 2013 Jan 15; 92(2):285-6. PubMed ID: 22941307
    [No Abstract] [Full Text] [Related]

  • 16. Molecular Pathogenesis of MDS.
    Look AT.
    Hematology Am Soc Hematol Educ Program; 2005 Jan 15; ():156-60. PubMed ID: 16304374
    [Abstract] [Full Text] [Related]

  • 17. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review.
    Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC.
    Leukemia; 1995 Oct 15; 9(10):1628-30. PubMed ID: 7564500
    [Abstract] [Full Text] [Related]

  • 18. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders.
    Werner M, Nolte M, Kaloutsi V, Buhr T, Kausche F, Georgii A.
    Lab Invest; 1995 Apr 15; 72(4):405-10. PubMed ID: 7723278
    [Abstract] [Full Text] [Related]

  • 19. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M, Strömbeck B, Olofsson T, Mitelman F, Johansson B.
    Genes Chromosomes Cancer; 2001 Dec 15; 32(4):302-10. PubMed ID: 11746971
    [Abstract] [Full Text] [Related]

  • 20. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
    Djordjević V, Dencić-Fekete M, Jovanović J, Drakulić D, Stevanović M, Janković G, Gotić M.
    Cancer Genet Cytogenet; 2008 Oct 15; 186(1):12-8. PubMed ID: 18786437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.